Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- sulbactam no separate page
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Contraindications
- Hypersensitivity to sulbactam, cefoperazone or other beta-lactams
Dosing: Adult
- Susceptible infections (adults, 1:1 product): 2 to 4 g/day IV or IM in divided doses every 12 hours; up to 8 g/day (sulbactam maximum 4 g/day)
Dosing: Altered kidney function
Sulbactam is cleared by the kidneys (about 84% in urine; half-life 6.9 to 9.7 hours in anephric patients), whereas cefoperazone is mainly excreted in bile. The label therefore caps sulbactam at 1 g every 12 hours at creatinine clearance (CrCl) 15–30 mL/min and 500 mg every 12 hours below 15, allowing extra cefoperazone alone for severe infections, and doses after dialysis. It has no US FDA label.
Kidney function measure: Summary of product characteristics uses creatinine clearance (CrCl, mL/min); thresholds 30 and 15.
Show full dosing details
- CrCl ≥60 mL/min
- Usual: 2 to 4 g/day of the 1:1 combination IV or IM in divided doses every 12 hours; up to 8 g/day in severe infection; maximum sulbactam 4 g/day (SmPC).
- CrCl 30–59 mL/min
- No adjustment above CrCl 30 (SmPC).
- CrCl 15–29 mL/min
- CrCl 15–30: maximum sulbactam 1 g every 12 hours (2 g/day of the 1:1 product). Extra cefoperazone may be given separately for severe infection (SmPC).
- CrCl <15 mL/min (not on dialysis)
- CrCl <15: maximum sulbactam 500 mg every 12 hours (1 g/day of the 1:1 product). Extra cefoperazone may be given separately (SmPC).
- Hemodialysis (intermittent)
- Dose as for CrCl <15 (sulbactam maximum 500 mg every 12 hours); give the dose after dialysis, because hemodialysis markedly alters sulbactam kinetics (SmPC).
- Peritoneal dialysis
- No PD-specific data; dose as for CrCl <15.
- CRRT
- No data in the SmPC. Specialist input.
- Dialyzable? Sulbactam: yes (hemodialysis significantly changes its clearance). Cefoperazone: half-life only slightly reduced (SmPC).
- Monitoring Prothrombin time and bleeding (vitamin K deficiency; fatal hemorrhage reported), especially with poor intake, malabsorption, prolonged IV feeding or anticoagulants; give vitamin K if needed. Avoid alcohol during and for 5 days after. Kidney function with aminoglycosides. In combined hepatic and kidney impairment, cefoperazone no more than 2 g/day without level monitoring (SmPC). Watch for confusion, myoclonus or seizures in kidney failure (cephalosporin neurotoxicity); consider vitamin K and check INR in dialysis patients with poor intake.
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual weight-based dose (SmPC).
- eGFR 30–59
- No pediatric kidney dosing in the SmPC; sulbactam is renally cleared, so reduce by analogy with adults. Specialist input.
- eGFR 15–29
- No pediatric kidney dosing in the SmPC; sulbactam is renally cleared, so reduce by analogy with adults. Specialist input.
- eGFR <15 (not on dialysis)
- No pediatric kidney dosing in the SmPC; sulbactam is renally cleared, so reduce by analogy with adults. Specialist input.
- Hemodialysis (intermittent)
- No pediatric data.
- Peritoneal dialysis
- No pediatric data.
- CRRT
- No pediatric data.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
Source: EFDA (Ethiopia) product information (July 25, 2023). This generic has no US FDA label.
Dosing: Pediatric
- Approved ages
- Children, including neonates (limited data in premature infants) (SmPC).
- Usual dose
- 40 to 80 mg/kg/day of the 1:1 combination in 2 to 4 divided doses; up to 160 mg/kg/day in serious infections; maximum sulbactam 80 mg/kg/day. First-week neonates: every 12 hours (SmPC).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedDosage forms
Philippines
- Powder for injection: 1 g, 1 g/500 mg, 2 g, 500 mg, 500 mg/500 mg
Registered products in the Philippines
33 products registered with the Food and Drug Administration (FDA) Philippines list Cefoperazone + Sulbactam as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products33
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
BiozamCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type III glass vial with rubber stopper and flip off seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | 228 Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-10525-04 | Sep 22, 2031 | |
BiozamCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M/I.V.)20 mL capacity Type III clear and colorless glass vial with gray butyl rubber stopper and aluminum seal with magenta PP flip-off cap (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | 228 Pharma TradingImporter: Sanimed Pharmaceuticals Inc.Trader: Aquatic Remedies Pvt. Ltd. | DRP-11176-01 | Feb 16, 2027 | |
Biozone 1.5Cefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial Box of 1's | Rx | Swiss Parenterals Ltd.India | 228 Pharma TradingImporter: Ambica International Corporation | DRP-6950 | Dec 14, 2031 | |
C-BactumCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g Powder for Injection (IV/IM)20 mL-capacity USP Type III Glass Vial with rubber plug and dark gray flip-off aluminum seal (Box of 1's) | Rx | VHB Medi Sciences LtdIndia | Brady Pharma Inc. | DR-XY48867 | Sep 6, 2028 | |
CefbacCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (I.M./I.V.)15 mL-capacity USP Type III clear and colorless glass vial with grey bromobutyl rubber stopper and aluminum seal with red flip-off cap + 10 mL (net content) LDPE ampoule containing Sterile Water for Injection as diluent (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Greencore Pharma, Inc. | DRP-10538 | Oct 14, 2031 | |
CeflaurCefoperazone (as sodium) + Sulbactam (as sodium) | g/500 mg Powder for Injection (IM/IV)20 mL-capacity USP Type III clear glass vial with rubber stopper and aluminum green flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DRP-16681 | Jun 5, 2030 | |
CefobactCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (I.M./I.V.)20 mL capacity Type III clear and colorless glass vial with gray butyl rubber stopper and aluminum seal with magenta PP flip-off cap (Box of l's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Sanimed Pharmaceuticals Inc.Trader: Aquatic Remedies Pvt. Ltd. | DRP-11176 | Feb 16, 2027 | |
CefohilCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M./I.V.)20 mL capacity Type III clear and colorless glass vial with gray butyl rubber stopper and aluminum seal with magenta PP flip-off cap (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc.Trader: Aquatic Remedies Ltd. | DRP-11176-02 | Feb 16, 2027 | |
CefosultamCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g / 500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Tamiga Pharmaceuticals SupplyImporter: Ambica International Corporation | DRP-6950-02 | Oct 30, 2031 | |
CefosultamCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (IM/IV)USP Type III Glass Vial with Rubber Stopper and Flip-Off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Tamiga Pharmaceuticals SupplyImporter: Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-10525-03 | Aug 29, 2031 | |
CefozolCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (as active) + LDPE Plastic Ampoule in 10 mL (net content as diluent) (Box of 1's) | Rx | Swiss Parenterals Pvt. Ltd.India | Endure Medical, Inc.Importer: Endure Medical, inc. | DR-XY46572 | May 22, 2029 | |
CefriotamCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type III glass vial with rubber stopper and flip off seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-10525 | Oct 11, 2031 | |
CefsukeerCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | L'Keeran EnterprisesImporter: Ambica International Corporation | DRP-6950-05 | Oct 14, 2031 | |
Efozone-SCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g Powder for Injection (I.M./1.V.)USP Type I Clear and Colorless Glass Vial with Butyl Rubber Stopper and Aluminum Seal with Blue PP Flip Off Cap Individually Packed in a Carton (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Co., LimitedChina | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-11688 | Apr 13, 2027 | |
FosularCefoperazone (as sodium) + Sulbactam (as sodium) | 1g Powder for Injection (IM/IV)Type I Clear Borosilicate Glass Vial Sealed with Gray Rubber Stopper and Yellow Aluminum Flip-Off Seal Cap x l's (Box of 1's) | Rx | PT. Etercon PharmaIndonesia | Importer: Prosweal Healthcare, Inc. | DR-XY47709 | Feb 28, 2027 | |
Hi-PerazoneCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g / 500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | HLM Pharmaceutical Inc.Importer: Ambica International Corporation | DRP-6950-07 | Oct 16, 2031 | |
Kephazon-S qCefoperazone (as sodium) + Sulbactam (as sodium) | 500 mg/500 mg Powder for Injection (IM/IV)20 mL-capacity USP type I clear glass vial with rubber stopper and blue flip-off seal (box of 10's individually pack vials) | Rx | United Biotech Pvt. Ltd.India | Central West Medicale Inc. | DRP-15146 | May 16, 2029 | |
Oritaxim-FCefoperazone (as sodium) + Sulbactam (as sodium) | 500 mg/500 mg Powder for Injection (I.M./I.V.)20 mL-capacity Type III clear and colorless glass vial with grey butyl rubber stopper and aluminum seal with red plastic flip-off cap (Box of 1's) | Rx | Cadila Pharmaceuticals Limited.India | S.M.H.P. Marketing & Consultancy | DRP-14653 | Nov 16, 2028 | |
Pyrazone-SCefoperazone (as sodium) + Sulbactam (as sodium) | 2 g Powder for Injection (I.M./I.V.)10 mL-Capacity USP Type III Clear and Colorless Glass Vial with Butyl Rubber Stopper and Aluminum Seal with Blue PP Flip-Off Cap Individually Packed in a Carton (Box of 10's) | Rx | NCPC Hebei Huamin Pharmaceutical Co., LimitedChina | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-11659 | Apr 7, 2027 | |
RazonamCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (I.M./I.V.)15 mL clear USP Type III clear glass vial, gray bromobutyl rubber stopper and red flip-off seal (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Hexagon Pharmaceuticals | DR-XY47683 | Jan 31, 2027 | |
Saphtazone-1500Cefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL-capacity USP Type I Amber Glass Vial with bromobutyl rubber stopper and dark pink aluminum seal (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd | DRP-14307 | Aug 16, 2028 | |
Saphtazone-1500Cefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL-capacity USP Type I Amber Glass Vial with bromobutyl rubber stopper and dark pink aluminum seal (Box of 1's) | Rx | Kilitch Drugs (India) Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14308 | Aug 16, 2028 | |
SulbacefCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/500 mg Powder for Injection (I.V./I.M.)USP Type III Glass Vial x 20mL (Box of 1's) | Rx | Cosmas Research Lab Ltd.India | Endure Medical, Inc. | DR-XY44359 | Mar 25, 2030 | |
SulbazonCefoperazone (as Sodium)+ Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial x 1 (Box of 10's) | Rx | Karnataka Antibiotics & Pharmaceuticals LimitedIndia | Phil. Pharmawealth, Inc. | DR-XY40541 | Jan 18, 2032 | |
SulperazeCefoperazone (as sodium) + Sulbactam (as sodium) | 1g/500 mg Powder for Injection (IM/IV)20 mL-capacity USP Type III clear glass vial with rubber stopper and aluminum flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Penta Labs Australia (Philippines)Trader: U Square Lifescience Pvt. Ltd. | DRP-16682 | Jun 5, 2030 | |
SuprazonCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g / 500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | BSV Bioscience Phils. Inc.Importer: Ambica International Corporation | DRP-6950-06 | Oct 30, 2031 | |
SuprazonCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type III glass vial with rubber stopper and flip off seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | BSV Bioscience Phils. Inc.Importer: Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-10525-01 | Sep 22, 2031 | |
VaczucefCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Pharma King DistributorImporter: Ambica International Corporation | DRP-6950-04 | Oct 30, 2031 | |
WinpersulCefoperazone (as sodium) + Sulbactam (as sodium) | 1 g/ 500 mg Powder for Injection (I.M./I.V.)USP Type III glass vial with rubber stopper and flip off seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Winter Pharmaceutical Product DistributionImporter: Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-10525-02 | Sep 22, 2031 | |
WinpersulCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g/500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | BioRx Pharma Labs LLPIndia | Winter Pharmaceutical Product DistributionImporter: Ambica International Corporation | DRP-6950-03 | Dec 14, 2026 | |
XefrizilCefoperazone + Sulbactam | 500 mg/ 500 mg Powder for Injection (I.V./ I.M.)20 mL USP Type III Clear Glass Vial (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DRP-14988 | Sep 14, 2027 | |
XefrizilCefoperazone + Sulbactam | 500 mg/500 mg Powder for Injection (I.V./I.M.)20 mL USP Type III Clear Glass Vial (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish, Inc. | DR-XY48334 | Sep 14, 2027 | |
ZulbCefoperazone (as Sodium) + Sulbactam (as Sodium) | 1 g / 500 mg Powder for Injection (IM/IV)20 mL USP Type I Plain Glass Vial (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Jazmark PharmaceuticalImporter: Ambica International Corporation | DRP-6950-01 | Oct 9, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Alcohol | Avoid | Flushing, sweating, headache, tachycardia (disulfiram-like). | Avoid during and for 5 days after. |
| Aminoglycosides | Adjust or monitor | Physical incompatibility; additive nephrotoxicity. | Do not mix; separate lines; monitor kidney function. |
| Oral anticoagulants | Adjust or monitor | Vitamin K deficiency and bleeding. | Monitor prothrombin time. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewedAdverse reactions
Common
- Diarrhea
- Rash
Serious
- Bleeding from vitamin K deficiency (fatal cases)
- Anaphylaxis
- Stevens-Johnson syndrome, toxic epidermal necrolysis
- Clostridioides difficile colitis
Monitoring parameters
- Prothrombin time and bleeding (vitamin K deficiency; fatal hemorrhage reported), especially with poor intake, malabsorption, prolonged IV feeding or anticoagulants; give vitamin K if needed. Avoid alcohol during and for 5 days after. Kidney function with aminoglycosides. In combined hepatic and kidney impairment, cefoperazone no more than 2 g/day without level monitoring (SmPC). Watch for confusion, myoclonus or seizures in kidney failure (cephalosporin neurotoxicity); consider vitamin K and check INR in dialysis patients with poor intake. Kidney
- Prothrombin time in at-risk patients
- Kidney function
Pharmacokinetics
Key PK parameters
| Half-life | Sulbactam about 1 hour; cefoperazone about 1.7 hours |
|---|---|
| Half-life in kidney failure (ESKD) kidney | Sulbactam 6.9 to 9.7 hours in anephric patients; cefoperazone unchanged (prolonged 2- to 4-fold in severe liver disease) |
| Renal excretion kidney | Sulbactam about 84% in urine; cefoperazone about 25% (rest biliary) |
| Dialyzability kidney | Sulbactam yes; cefoperazone slightly |
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Ethiopian Food and Drug Authority. Cerazone Plus-500 SmPC (SANCE/IND/770) [EFDA (Ethiopia) product information, July 25, 2023; no US FDA label]. https://www.efda.gov.et/wp-content/uploads/2023/10/Cefoperazone-Sulbactam-Injection-_CERAZONE-PLUS-500_Sance-Laboratories-Private-Limited.pdf
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- Sance Laboratories Private Limited. (2023). Cerazone Plus-500 (cefoperazone/sulbactam 500 mg/500 mg) dry powder for injection [Summary of product characteristics, MA SANCE/IND/770; text revised July 25, 2023]. Ethiopian Food and Drug Authority. https://www.efda.gov.et/wp-content/uploads/2023/10/Cefoperazone-Sulbactam-Injection-_CERAZONE-PLUS-500_Sance-Laboratories-Private-Limited.pdf
- Grill, M. F., & Maganti, R. (2008). Cephalosporin-induced neurotoxicity: Clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. The Annals of Pharmacotherapy, 42(12), 1843–1850. https://doi.org/10.1345/aph.1L307
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .